Top Medicine Researchers at Oregon Health & Science University for 2026

Oregon Health & Science University’s recent work in Medicine spans a wide range of clinical and translational questions, from dermatology and cardiometabolic care to pulmonary research and public health. The articles below reflect a research community moving across specialties while still sharing a strong focus on patient care, measurement, and better treatment decisions.

As you browse, you’ll see how investigators at the institution are contributing to active conversations in common medical subfields, often connecting specialist practice with broader questions in epidemiology, outcomes, and care access.

Featured Researchers

A.D. Fryer

A.D. Fryer’s recent work at Oregon Health & Science University spans dermatology, plant science, and small animals, with studies ranging from maternal diet and offspring airway biology to fragrance ingredient safety assessments.

Activity over the last year: 157 indexed journal articles.

Top publications:

• Maternal high-fat diet programs offspring airway hyperinnervation and hyperresponsiveness (Jan 2025)
• Update to RIFM fragrance ingredient safety assessment, hydroxycitronellal dimethyl acetal, CAS Registry number 141-92-4 (May 2025)
• RIFM fragrance ingredient safety assessment, 1-octanol, CAS registry number 111-87-5 (Apr 2025)

Eric L. Simpson

Eric L. Simpson is focused on dermatology, immunology and allergy, and physiology, with recent publications centered on atopic dermatitis treatment programs, safety analyses, and treatment-switch outcomes.

Activity over the last year: 67 indexed journal articles.

Top publications:

• ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis (Jan 2025)
• Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age (Mar 2025)
• Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE (Feb 2025)

Ahmad Masri

Ahmad Masri’s recent publications at Oregon Health & Science University concentrate on cardiology and cardiovascular medicine, including obstructive hypertrophic cardiomyopathy, cardiac amyloidosis, and transthyretin amyloid cardiomyopathy.

Activity over the last year: 55 indexed journal articles.

Top publications:

• Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy (Aug 2025)
• The Last Decade in Cardiac Amyloidosis (Jan 2025)
• Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy (Mar 2025)

Marco Colasurdo

Marco Colasurdo’s work bridges epidemiology, pulmonary and respiratory medicine, and neurology, with recent studies on aspiration thrombectomy and middle meningeal artery embolization for subdural hematoma.

Activity over the last year: 58 indexed journal articles.

Top publications:

• SUMMIT MAX: A Randomized Trial of the Super Large Bore HiPoint Reperfusion System Versus Vecta System for Aspiration Thrombectomy (May 2025)
• Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma: A Meta-Analysis of Large Randomized Controlled Trials (Apr 2025)
• Standalone Middle Meningeal Artery Embolization Versus Conservative Management for Nontraumatic Subdural Hematoma (Apr 2025)

Maria Fleseriu

Maria Fleseriu’s recent output combines endocrinology, surgery, and epidemiology, including consensus work on acromegaly outcomes, pituitary surgery research, and pituitary incidentaloma guidance.

Activity over the last year: 34 indexed journal articles.

Top publications:

• Consensus on acromegaly therapeutic outcomes: an update (Aug 2025)
• A core outcome set for pituitary surgery research: an international delphi consensus study (Jul 2025)
• Pituitary incidentaloma: a Pituitary Society international consensus guideline statement (Jun 2025)

Alex G. Ortega‐Loayza

Alex G. Ortega‐Loayza’s publications link epidemiology, dermatology, and pathology, with recent papers on diagnostic criteria for metastatic cutaneous Crohn disease, pyoderma gangrenosum, and its clinical mimickers.

Activity over the last year: 26 indexed journal articles.

Top publications:

• Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease (May 2025)
• Clinical Mimickers Misdiagnosed as Pyoderma Gangrenosum (Mar 2025)
• High frequency ultrasound for pyoderma gangrenosum: A case series (Jun 2025)

Richard T. Maziarz

Richard T. Maziarz’s recent work in hematology and oncology addresses venetoclax outcomes in acute myeloid leukemia, CAR T-cell therapy access, and prevention of IEC therapy–associated CRS.

Activity over the last year: 34 indexed journal articles.

Top publications:

• Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study (May 2025)
• Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis (May 2025)
• Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study (Mar 2025)

Patrick G. Lyons

Patrick G. Lyons is working across epidemiology, public health, and pulmonary medicine, with recent articles on ICU data standards, respiratory failure prediction, and extracting echocardiogram entities using large language models.

Activity over the last year: 30 indexed journal articles.

Top publications:

• A common longitudinal intensive care unit data format (CLIF) for critical illness research (Mar 2025)
• Can we predict the future of respiratory failure prediction? (Jun 2025)
• EchoLLM: extracting echocardiogram entities with light-weight, open-source large language models (Jul 2025)

What Oregon Health & Science University's Medicine Community Is Working On

Across Oregon Health & Science University’s Medicine research, epidemiology appears most often, underscoring a strong interest in study design, outcomes, and population-level evidence. Dermatology is another major thread, especially where clinical characterization and treatment questions overlap with allergy and pathology. Pulmonary and respiratory medicine, along with public health, environmental, and occupational health, round out a portfolio that shows active attention to both specialty care and the systems, data, and access issues that shape it. Plant science appears more narrowly, but it highlights the breadth of inquiry represented in the institution’s recent work.

• Epidemiology - seen across 4 of the featured researchers
• Dermatology - seen across 3 of the featured researchers
• Pulmonary and Respiratory Medicine - seen across 2 of the featured researchers
• Public Health, Environmental and Occupational Health - seen across 2 of the featured researchers
• Plant Science - seen across 1 of the featured researchers

Together, these projects show a research community engaged with both immediate clinical questions and the methods that help answer them well. If you want to keep track of similar work, Resub can help streamline citation discovery, manuscript formatting, and submission preparation for your own projects.

Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.